Sellas Life Sciences: Options Traders Pile In as a Leukemia Trial Reaches Its Defining Threshold ()
The choices market not often speaks this loudly. On Friday, merchants swapped 79,890 name contracts on Sellas Life Sciences — a quantity surge of roughly 103 % above the standard every day tempo — whereas the underlying shares climbed 13 % in a single session. When name exercise practically doubles in someday, the market isn’t…